Your browser doesn't support javascript.
loading
Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression.
Westerlund, Isabelle; Shi, Yao; Toskas, Konstantinos; Fell, Stuart M; Li, Shuijie; Surova, Olga; Södersten, Erik; Kogner, Per; Nyman, Ulrika; Schlisio, Susanne; Holmberg, Johan.
Afiliação
  • Westerlund I; Department of Cell and Molecular Biology, Ludwig Institute for Cancer Research, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Shi Y; Department of Cell and Molecular Biology, Ludwig Institute for Cancer Research, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Toskas K; Department of Cell and Molecular Biology, Ludwig Institute for Cancer Research, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Fell SM; Department of Cell and Molecular Biology, Ludwig Institute for Cancer Research, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Li S; Department of Cell and Molecular Biology, Ludwig Institute for Cancer Research, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Surova O; Department of Microbiology, Tumor and Cellbiology, Karolinska Institutet, 171 65 Solna, Sweden.
  • Södersten E; Department of Cell and Molecular Biology, Ludwig Institute for Cancer Research, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Kogner P; Department of Cell and Molecular Biology, Ludwig Institute for Cancer Research, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Nyman U; Department of Women's and Children's Health, Karolinska Institutet, 171 76 Stockholm, Sweden.
  • Schlisio S; Department of Cell and Molecular Biology, Ludwig Institute for Cancer Research, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Holmberg J; Department of Cell and Molecular Biology, Ludwig Institute for Cancer Research, Karolinska Institutet, 171 77 Stockholm, Sweden.
Proc Natl Acad Sci U S A ; 114(30): E6137-E6146, 2017 07 25.
Article em En | MEDLINE | ID: mdl-28696319

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Azacitidina / Tretinoína / Terapia Genética / Proliferação de Células / Fatores de Transcrição Hélice-Alça-Hélice Básicos / Neuroblastoma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Azacitidina / Tretinoína / Terapia Genética / Proliferação de Células / Fatores de Transcrição Hélice-Alça-Hélice Básicos / Neuroblastoma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia